DYRK2 and cancer: High nuclear levels of DYRK2 and heat shock factor 1 (HSF1) have been detected in triple-negative breast cancer (TNBC) tissues, and high nuclear DYRK2 levels significantly reduced cancer-specific survival in TNBC and triple- and AR-negative patient samples [36].